In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic <i>E. coli</i>

In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic <i>E. coli</i>

<b>Background:</b> Urinary tract infections (UTIs) caused by the multidrug resistance (MDR) phenotype termed extended-spectrum beta lactamase (ESBL)-producing <i>E. coli</i> is a significant and growing global health concern. In response to the rising prevalence, the novel Be...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali Atoom, Bayan Alzubi, Dana Barakat, Rana Abu-Gheyab, Dalia Ismail-Agha, Awatef Al-Kaabneh, Nawfal Numan
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Antibiotics
Subjects:
beta-lactam antibiotics
beta-lactamase inhibitors
extended-spectrum beta-lactamase
cefaclor
<i>Escherichia coli</i>
clavulanic acid
Online Access:https://www.mdpi.com/2079-6382/14/6/603
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items